|
PDS5A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.829820E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.743600E-02 |
| Normal-vs-Stage2 |
1.409730E-02 |
| Normal-vs-Stage3 |
4.395900E-03 |
| Normal-vs-Stage4 |
1.352190E-02 |
| Stage1-vs-Stage2 |
1.987440E-01 |
| Stage1-vs-Stage3 |
8.844300E-02 |
| Stage1-vs-Stage4 |
2.227400E-01 |
| Stage2-vs-Stage3 |
9.700000E-01 |
| Stage2-vs-Stage4 |
9.283200E-01 |
| Stage3-vs-Stage4 |
9.474000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.769560E-02 |
| Normal-vs-AfricanAmerican |
3.158600E-01 |
| Normal-vs-Asian |
7.878500E-02 |
| Caucasian-vs-AfricanAmerican |
5.578600E-01 |
| Caucasian-vs-Asian |
8.144400E-01 |
| AfricanAmerican-vs-Asian |
6.988200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.043600E-02 |
| Normal-vs-Female |
1.919730E-02 |
| Male-vs-Female |
8.382800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.419200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.103000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.943200E-03 |
| Normal-vs-Age(81-100Yrs) |
1.647010E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.821200E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.424450E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.143400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.630000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.179000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.669800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.215600E-01 |
| Classical-VS-Follicular |
2.062200E-02 |
| Classical-VS-Other |
4.492600E-01 |
| Classical-VS-Normal |
1.212410E-01 |
| Tall-VS-Follicular |
5.258200E-01 |
| Tall-VS-Other |
7.258800E-01 |
| Tall-VS-Normal |
7.381600E-02 |
| Follicular-VS-Other |
9.817800E-01 |
| Follicular-VS-Normal |
4.061700E-03 |
| Other-VS-Normal |
1.637370E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.819600E-03 |
| Normal-vs-N1 |
2.047800E-02 |
| N0-vs-N1 |
9.487600E-01 |
|
|
